NeuroPace Inc【NPCE】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 11,217 12,630 10,339 10,997 11,374 10,200 11,157 12,789 14,472 16,510 16,427 18,012 18,124 19,256 21,060 21,466 22,524 23,520 27,354 26,588
売上成長率(%) - - - - 19.2 24.3 22.1 29.9 23.9
売上原価 2,724 3,271 2,832 2,921 3,115 2,734 3,192 3,986 4,100 4,538 4,194 4,467 4,781 5,122 5,640 5,278 5,182 5,388 6,186 6,010
売上総利益 8,493 9,359 7,507 8,076 8,259 7,466 7,965 8,803 10,372 11,972 12,233 13,545 13,343 14,134 15,420 16,188 17,342 18,132 21,168 20,578
売上総利益率(%) 75.4 77.0 77.1 77.4 77.4
研究開発費 4,100 4,437 4,329 5,345 5,577 5,669 5,611 5,089 5,263 5,343 4,795 5,377 5,784 6,065 5,754 6,050 7,440 6,845 6,576 7,027
販売管理費 8,267 9,527 9,421 11,746 12,444 12,771 12,553 13,573 13,428 14,483 13,388 13,219 15,104 14,299 13,909 13,791 15,049 - - -
営業費用 12,367 13,964 13,750 17,091 18,021 18,440 18,164 18,662 18,691 19,826 18,183 18,596 20,888 20,364 19,663 19,841 22,489 24,956 23,768 22,345
営業利益 -3,874 -4,605 -6,243 -9,015 -9,762 -10,974 -10,199 -9,859 -8,319 -7,854 -5,950 -5,051 -7,545 -6,230 -4,243 -3,653 -5,147 -6,824 -2,600 -1,767
営業利益率 (%) -17.0 -22.9 -29.0 -9.5 -6.6
純利益 -8,800 -8,494 -8,083 -10,693 -11,461 -12,690 -11,785 -11,146 -10,375 -9,124 -7,257 -6,200 -8,925 -7,514 -5,452 -5,250 -6,589 -8,651 -3,496 -2,729
純利益率(%) -24.5 -29.3 -36.8 -12.8 -10.3
一株あたり利益 -32.73 -0.48 -0.34 -0.36 -0.47 -0.52 -0.48 -0.44 -0.41 -0.36 -0.28 -0.22 -0.32 -0.26 -0.19 -0.17 -0.21 -0.26 -0.11 -0.08
希薄化後一株あたり利益 -32.73 -0.48 -0.34 -0.36 -0.47 -0.52 -0.48 -0.44 -0.41 -0.36 -0.28 -0.22 -0.32 -0.26 -0.19 -0.17 -0.21 -0.26 -0.11 -0.08